MCL-1 knockdown was achieved using a pool of prevalidated siRNA to human MCL-1 s8583 (Ambion/Life Technologies, UK) at 5 nM concentration or non-targeting control siRNA and nucleofection using Amaxa kit (Lonza, UK) according to the manufacturer's protocol. '